Results 141 to 150 of about 18,220 (284)
Allergy, Volume 81, Issue 5, Page 1548-1570, May 2026.This meta‐analysis included 2292 patients with severe asthma who underwent biologic switching across 23 countries/regions. The most prevalent switching pattern was from mepolizumab to benralizumab, with suboptimal asthma control being the primary reason.
Yang Zheng +13 more
wiley +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
Cutaneous and mucosal manifestations associated with celiac disease [PDF]
, 2018 Beteta Gorriti, Valia Patricia +6 more
core +2 more sources
Positive CD63 Basophil Activation Tests Are Common in Children with Chronic Spontaneous Urticaria and Linked to High Disease Activity [PDF]
, 2016 Elena Netchiporouk +5 more
openalex +1 more source
Cosmetic Adverse Reactions and Prognostic Factors: A Retrospective Cohort Study in Wuhan, China
Contact Dermatitis, Volume 94, Issue 5, Page 475-481, May 2026.This study reveals that being under 20 or having a history of allergies significantly increases the risk of long‐term symptoms after a cosmetic adverse reaction. These findings help dermatologists identify high‐risk patients for proactive management and tailored preventive strategies.
Ayan Hasen +4 more
wiley +1 more source
Autoimmune chronic spontaneous urticaria [PDF]
Journal of Allergy and Clinical Immunology, 2018 openaire +2 more sources
The Clinical Respiratory Journal, Volume 20, Issue 5, May 2026.This study preliminarily concludes that the extent of destroyed lung, whether preoperative CTA, technical factors, and the progression of underlying diseases are independent risk factors associated with hemoptysis recurrence after bronchial artery embolization (BAE). Through comprehensive preoperative assessments, individualized embolization strategies,
Tianhua Yue, Ling Li, Zhengyu Yue
wiley +1 more source
Clinical and Translational Science, Volume 19, Issue 5, May 2026.ABSTRACT The approval of baricitinib and ritlecitinib for alopecia areata (AA) marks the beginning of the Janus kinase (JAK) inhibitor era in AA treatment. Tofacitinib, a first‐generation JAK1/3 inhibitor, has theoretical potential to treat AA; however, real‐world evidence, particularly on comparative outcomes across patient subgroups and patient ...
Yifan Jin +7 more
wiley +1 more source
Wells syndrome: clinical findings and treatment management in a large cohort of 48 patients
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 5, Page 644-656, May 2026.Summary Background and Objectives: Wells syndrome (WS) is a rare inflammatory skin disorder typically characterized by erythematous, edematous, and pruritic plaques. Despite its distinct histopathological features, WS remains an underdiagnosed disease due to its variable clinical presentations and overlap with other dermatological conditions.
Marco Adriano Chessa +8 more
wiley +1 more source